| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| povidon 5 % øjendråber til engangsbrug |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Povidone (substance) |
Inferred relationship |
Some |
|
| Product containing povidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| povidon mundskyllevæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Povidone (substance) |
Inferred relationship |
Some |
|
| povindon + natriumhyaluronat oral gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Povidone (substance) |
Inferred relationship |
Some |
|
| glycyrrhetinsyre + hyaluronatnatrium + polyvinylpyrrolidon |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Povidone (substance) |
Inferred relationship |
Some |
|
| Polyvinyl pyrrolidone disease |
Causative agent |
False |
Povidone (substance) |
Inferred relationship |
Some |
|
| glycyrrhetinsyre + hyaluronatnatrium + polyvinylpyrrolidon pulver til oral gel, pakke a 15 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Povidone (substance) |
Inferred relationship |
Some |
|
| Product containing povidone in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Povidone (substance) |
Inferred relationship |
Some |
|
| Povidone-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing povidone in oropharyngeal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Povidone 5% conventional release eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Povidone (substance) |
Inferred relationship |
Some |
|
| Product containing enoxolone and hyaluronic acid and povidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
2 |
| Povidone-containing product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only enoxolone and hyaluronic acid and povidone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
2 |
| Povidone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only povidone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Povidone only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing only povidone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Povidone 50 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Povidone 50 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Polyvinyl pyrrolidone disease |
Causative agent |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing povidone in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Polyvinyl alcohol- and povidone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Polyvinyl alcohol and povidone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Product containing polyvinyl alcohol and povidone in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Polyvinyl alcohol 14 mg/mL and povidone 6 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Polyvinyl alcohol 14 mg/mL and povidone 6 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
| Polyvinyl alcohol and povidone only product in ocular dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Povidone (substance) |
Inferred relationship |
Some |
1 |
FHIR